Artiva biotherapeutics to participate in the jefferies london healthcare conference

San diego, nov. 11, 2024 (globe newswire) -- artiva biotherapeutics, inc. (nasdaq: artv), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases and cancers, today announced that management will participate in a fireside chat at the jefferies london healthcare conference on wednesday, november 20, 2024, at 3:30 p.m. gmt, in london, uk.
ARTV Ratings Summary
ARTV Quant Ranking